The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new biotechnology methods instead to spur innovation in the pharmaceutical ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min An Austin startup that has been ...

For more than a century, dentistry has focused on repairing or replacing damaged teeth, not growing new ones. That assumption is now under direct challenge, as Japanese teams move a first-of-its-kind ...

Following successful small-animal trials that confirmed bioequivalence, BioNxt is now taking the final preclinical step to prepare its sublingual Cladribine formulation for human testing. The upcoming ...